Kimberly A Huber

age ~56

from Avon, CT

Get Report

Also known as:

Kimberly Alyson Huber
Kimberly Avon Huber
Kimberly A Skoloff
Kim Huber
Kimbelry Huber
Kim A Skoloff
Kimberlya Huber
Ernest Huber

Phone and address:: 53 Zachary Dr, Avon, CT 06001
8603522298

Connected to:

Kimberly Huber Phones & Addresses

53 Zachary Dr, Avon, CT 06001 • 8603522298
Cumberland, RI
431 Greene Ln, Phoenixville, PA 19460 • 6109173779
King of Prussia, PA
Linville, NC
Pawtucket, RI
Drexel Hill, PA
Canton, CT

Work

Company:

Real Estate One
Address:
Phones:

8106672284

Images

Real Estate Brokers

Kimberly Huber, Lapeer County MI Broker

view source

Work:

Real Estate One
8106672284 (Phone)

Resumes

Writer

view source

Position:

Blogger at DiaperBuds, Social Media Director at NY Mom's World, Owner/Blogger at Try It, Mom!

Location:

West Babylon, New York

Industry:

Online Media

Work:

DiaperBuds since Feb 2012
Blogger
NY Mom's World since Jun 2011
Social Media Director
Try It, Mom! since 2009
Owner/Blogger
Wantagh Middle School 2005 - 2009
Teacher

Education:

Hofstra University 1999 - 2005
BA & MS, Dance, English, Education

Integration Manager

view source

Position:

Integration Manager at Digital Air Strike, Integration Manager at Digital Air Strike - ResponseLogix

Location:

Sunnyvale, California

Industry:

Computer Software

Work:

Digital Air Strike since Sep 2007
Integration Manager
Digital Air Strike - ResponseLogix since 2007
Integration Manager

Name / Title

Company / Classification

Phones & Addresses

Kimberly Huber
Secretary

NORTHWEST LAMINATING COMPANY, INC

Us Patents

Methods Of Treating Disorders With Group I Mglur Antagonists
view source
US Patent:

6916821, Jul 12, 2005
Filed:

Apr 4, 2003
Appl. No.:

10/408771
Inventors:

Mark F. Bear - Bristol RI, US
Kimberly M. Huber - Dallas TX, US
Stephen T. Warren - Atlanta GA, US
Assignee:

Brown University - Providence RI
Emory University - Atlanta GA
International Classification:

A61K031/435
US Classification:

514277, 514315, 514317, 514330, 514345, 514381, 514556
Abstract:

mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.

Methods Of Treating Disorders With Group I Mglur Antagonists
view source
US Patent:

7648993, Jan 19, 2010
Filed:

Dec 17, 2004
Appl. No.:

11/015328
Inventors:

Mark F. Bear - Bristol RI, US
Kimberly M. Huber - Dallas TX, US
Stephen T. Warren - Atlanta GA, US
Assignee:

Brown University - Providence RI
Emory University - Atlanta GA
International Classification:

A61K 31/435
A61K 31/33
US Classification:

514277, 514183
Abstract:

mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.

Methods Of Treating Neurological Disorders With Group I Mglur Antagonists
view source
US Patent:

20030100539, May 29, 2003
Filed:

Apr 2, 2002
Appl. No.:

10/114433
Inventors:

Mark Bear - Bristol RI, US
Kimberly Huber - Dallas TX, US
Stephen Warren - Atlanta GA, US
International Classification:

A61K031/655
A61K031/47
A61K031/44
A61K031/4709
US Classification:

514/150000, 514/307000, 514/310000, 514/567000, 514/277000
Abstract:

Compositions and uses of mGluR5 antagonists for the treatment and prevention of neurological disorders, such as Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome, are disclosed.

Methods Of Treating Disorders With Group I Mglur Antagonists
view source
US Patent:

20100210542, Aug 19, 2010
Filed:

Jan 15, 2010
Appl. No.:

12/688408
Inventors:

Mark F. Bear - Bristol RI, US
Kimberly M. Huber - Dallas TX, US
Stephen T. Warren - Atlanta GA, US
International Classification:

A61K 38/16
A61P 25/18
A61P 25/00
US Classification:

514 12
Abstract:

mGluR5 antagonists are used for the treatment and prevention of disorders, including Fragile X, autism, mental retardation, schizophrenia and Down's Syndrome. The methods of the invention can be used to treat epilepsy and anxiety in a human having Fragile X syndrome, autism, mental retardation, schizophrenia and Down's Syndrome.